Article metrics
PDF
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Dementia
- Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease
- An algorithmic approach to structural imaging in dementia
- Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
- Presenile dementia syndromes: an update on taxonomy and diagnosis
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Brain imaging in dementia
- Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis